We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of a Nutritional Supplement on H&N Cancer Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2006 by Edward Hines Jr. VA Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00296452
First Posted: February 27, 2006
Last Update Posted: February 27, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Edward Hines Jr. VA Hospital
February 23, 2006
February 27, 2006
February 27, 2006
February 2006
Not Provided
severity of mucositis
Same as current
No Changes Posted
weight loss, quality of life
Same as current
Not Provided
Not Provided
 
Effect of a Nutritional Supplement on H&N Cancer Patients
The Effect of an Enhanced Nutritional Supplement on Head and Neck Cancer Patients
To determine if using a nutritionally enhanced supplement will improve mucositis in head and neck cancer patients
H&N cancer patients will be randomized to receive either a nutritionally enhanced product or standard treatment. The patients in both groups will receive nutritional counseling weekly by the RD. Anthropometric measures, available lab values, mucositis grade, and quality of life measures will be compared between groups.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Head and Neck Cancer
Behavioral: behavior
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
40
February 2006
Not Provided

Inclusion Criteria:

  • Head and neck cancer 1st.2nd wk Rx read &wrte eng

Exclusion Criteria:

  • receiving hospice impaired cognition
Sexes Eligible for Study: All
30 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00296452
0033
Not Provided
Not Provided
Not Provided
Not Provided
Edward Hines Jr. VA Hospital
Not Provided
Principal Investigator: Sharon Foley, MS Hines VA Hosptial
Principal Investigator: carol bier-laning, MD Hines VA Hospital
Edward Hines Jr. VA Hospital
February 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP